The correct way to take meloxicam and rizatriptan combination tablets (meloxicam and rizatriptan)

Meloxicam and rizatriptan combination tablet (meloxicam and rizatriptan) is a compound drug that combines the two active ingredients of meloxicam and rizatriptan. It is mainly used to treat acute attacks of migraine with or without aura in adult patients, bringing good news to many migraine patients. However, it is important to take this medication correctly to ensure that it works safely and effectively.

Before taking meloxicam and rizatriptan combination tablets, a clear diagnosis of migraine must be made because this drug is not indicated for the preventive treatment of migraines or the treatment of cluster headaches. Regarding the method of use and recommended dosage, it is recommended to take 1 tablets orally 1 times a day during each acute attack of migraine. The maximum daily dose is 1 tablets. Do not exceed this dose. Such dosage setting is based on the safety and effectiveness of the drug. Overdosing may increase the risk of adverse reactions without enhancing the therapeutic effect.

For special groups of people, medication needs to be adjusted carefully. Due to changes in body functions, the clinical response of the elderly may be different from that of young people. However, there is currently no clear information on the specific use and adjustment of this product in the elderly. The safety of the drug in pregnant and lactating women has not yet been determined, so it should be used with caution during these two special stages. For children, there is currently insufficient data to determine its safety and effectiveness, so use by children is not recommended.

In addition, the drug is contraindicated in patients with cardiovascular diseases such as ischemic heart disease, coronary vasospasm, stroke or transient ischemic attack, as well as patients with underlying diseases such as severe hypertension and renal insufficiency.

In short, meloxicam and rizatriptan combination tablets play an important role in the treatment of acute migraine attacks, but they must be used rationally in strict accordance with the indications, recommended dosages, and adjustments for special groups to ensure the safety and effectiveness of the medication.

Reference link:https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/215431s000lbl.pdf